Food and Drug Administration
Silver Spring, MD
Dr. Kevin Prohaska is the Associate Director of the Office of Clinical Policy (OCLiP) within the FDA Office of the Commissioner. His work at OCLiP includes serving as a senior medical policy advisor with a focus on human subjects’ protections including issues related to informed consent and bioethics. Dr. Prohaska is a board-certified Family Practice physician with a diverse professional background that includes academic, clinical, military, emergency, and regulatory medicine.
C04 - [IN-PERSON/RECORDED] Exception From Informed Consent (EFIC): Overview and Common Pitfalls
Monday, December 4, 2023
3:45 PM – 4:45 PM ET